Hemodialysis blood tubing sets comprises of arterial lines and venous lines, wherein the arterial lines are used to transport the blood from patients to the hemodialysis machine and the venous lines ensure in bringing the blood back from the hemodialyzer to the patient. The majority of the hemodialysis blood tubing sets have needle stick injury protecting guards and medication ports.
Detoxification is currently dominating the clinical application segment for hemodialysis blood tubing sets market. As per the recent research citings provided by the World Health Organization (WHO), the number of patients diagnosed with end-stage renal diseases (ESRD) continues to increase at a rate of 5-7% per year. The mineral balance will be showcasing comfortable market growth in the near future owing to the significant increase in the number of patients suffering from the electrolyte and acid-base disorders due to chronic kidney disease.
Browse the full report Hemodialysis Blood Tubing Sets – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hemodialysis-blood-tubing-sets-market
Hospitals and clinics are representing the largest market share in the end-user segment for hemodialysis blood tubing sets market. The rising prevalence of chronic kidney diseases (CKD) in patients worldwide has led to the subsequent increase in the inpatient visit to the government-sponsored hospitals for hemodialysis. Ambulatory surgical centers are expected to harness positive market growth during the forecast period on account of the proactive initiatives adopted by the government healthcare agencies to promote ambulatory surgical centers to reduce the healthcare burden associated with the point of care centers across the globe.
North America is reigning in the geography segment for hemodialysis blood tubing sets market. The rising prevalence of diabetic nephropathy primarily drives market growth in the region. As per the latest research citings provided by the Center for Disease Control and Prevention (CDC), approximately, 40% of the patients suffering from type 2 diabetes in the United States are reported to be suffering from diabetic nephropathy. Furthermore, the existence of key players such as Fresenius Kabi, Baxter AG, Nipro Corporation further accentuates the market growth in the region. Europe is placed 2nd in the regional segment for hemodialysis blood tubing sets market on account of the supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of hemodialysis blood tubing sets market. The Asia Pacific is anticipated to be the fastest-growing regional segment for hemodialysis blood tubing sets market chiefly due to the growing incidence of diabetic nephropathy in elderly patients and the increasing medical tourism industry.
Medical device manufacturers engaged in the production of hemodialysis blood tubing sets are Fresenius Kabi., Baxter AG., Nipro Corporation., Renax Biomedical Technology Co., Ltd., Asahi Kasei Medical Co., Ltd., Angiplast Private Limited., Perfect Medical Co., Ltd., Global Meditronic., Bain Medical Equipment (Guangzhou) Co Ltd., and George Philips Medical Engineering Pvt. Ltd.
Key Market Movements:
- Rising prevalence of end-stage renal diseases worldwide
- Significant increase in the number of patients suffering from the electrolyte and acid-base imbalance due to chronic kidney disease across the globe
- The supportive environment provided by the global regulatory agencies for the sale and distribution of hemodialysis tubing sets further propels the market growth